Search results for " First"

showing 10 items of 329 documents

Approaches used to care for carious primary molars among pediatric dentists and general dental practitioners in Saudi Arabia

2018

Background The aim of this cross sectional study was (1) to identify and compare the approaches which are used to care for carious primary molars between pediatric dentists (PDs) and general dental practitioners (GDPs) in Saudi Arabia and (2) to evaluate the knowledge level of the most appropriate treatment decisions for both groups with regard to caries in primary molars and its relation with demographic variables. Material and Methods A random sample of 600 GDPs and all registered PDs (n = 100) in the Saudi dental society in 2016 were emailed a two part questionnaire; the first part included questions about demographic data and the second part investigated knowledge of the participants of…

Molarbusiness.industryCross-sectional studyKnowledge levelResearchMEDLINEPulpotomyDentistry030206 dentistry:CIENCIAS MÉDICAS [UNESCO]Mandibular first molarCommunity and Preventive Dentistry03 medical and health sciences0302 clinical medicinestomatognathic systemUNESCO::CIENCIAS MÉDICASChi-square testMedicine030212 general & internal medicineOrdered logitbusinessGeneral DentistryJournal of Clinical and Experimental Dentistry
researchProduct

Establishing a diagnostic tool for assessing optimal treatment timing in Indian children with developing malocclusions

2011

Objective: To interrelate chronological age, cervical vertebrae maturational stage and dental calcification stages and to establish latter as first level diagnostic tool to estimate timing of pubertal growth spurt. Materials and Methods: Sample derived from pretreatment panaromic and lateral cephalometric radiographs of patients 8-14 years old. Study sample divided into three groups depending upon Angle’s molar relation: Group I, Group II, Group III. According to chronological age, into: Group A: 8-11 years Group B:11-14 years, further separating males and female subjects in each group. Demirjian et al method was used to assess dental maturity and for skeletal maturity the New Improved Vers…

Molarbusiness.industryOptimal treatmentDentistryBone ageOdontologíaMandibular first premolar:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludMandibular second molarmedicine.anatomical_structureStatistical significanceUNESCO::CIENCIAS MÉDICASmedicineChi-square testbusinessGeneral DentistryCervical vertebrae
researchProduct

Carthage's military installations of the First Punic War on Monte Pellegrino (Palermo)

2019

The excavation in the park of Villa Belmonte (Monte Pellegrino, Palermo) has brought to light several warehouses, made with a “pseudo-frame” technique, probably with a straw roof, used for the storage of foodstuffs, given the large quantity of Punic-type amphorae found in situ, datable to around the middle of the third century BC. In addition, a section of road - about 3 m wide that proceeds in the direction of WNW- ESE, consisting of two layers of use - has been intercepted. We believe to have tracked down part of a strategic/military station used by the Carthaginian army during the crucial years of the First Punic War.

Monte Pellegrino (Palermo) Carthaginian military station First Punic War Punic amphorae petrographyanfore punicheprima guerra punicaMonte Pellegrino (Palermo)lcsh:Archaeologylcsh:CC1-960petrografiaMonte Pellegrino (Palermo) Postazione cartaginese prima guerra punica anfore puniche petrografiaPostazione cartagineseParole chiave: Monte Pellegrino (Palermo) Postazione cartaginese prima guerra punica anfore puniche petrografia. Keywords: Monte Pellegrino (Palermo) Carthaginian military station First Punic War Punic amphorae petrography.Settore GEO/09 -Georis. Miner.e Appl.Mineral.-Petrogr. per l'Ambi.ed i B.Cult.
researchProduct

La Méthode como hermenéutica musical Homenaje a Edgar Morin por su 100º cumpleaños

2021

The present work addresses the principles and properties of the complex thought formulated by the French thinker Edgar Morin and the way in which he was able me to articulate his conception of organizational complexity with one of the most important theories of musical analysis, which emerged at the beginning of the 20th century: the schenkerian analysis. It is a review and extension of a few pages of my doctoral thesis, which are intended to pay tribute to who has been, in addition to my teacher, Honorary President of Itamar since its first issue. His teachings and support has always been the engine for my quest for musical organization. On July 21, 2021, Morin celebrated his 100th birthda…

Morin celebrated his 100th birthday. 25 51UNESCO::CIENCIAS DE LAS ARTES Y LAS LETRASwhich are intended to pay tribute to who has beenRosa The present work addresses the principles and properties of the complex thought formulated by the French thinker Edgar Morin and the way in which he was able me to articulate his conception of organizational complexity with one of the most important theories of musical analysisHonorary President of Itamar since its first issue. His teachings and support has always been the engine for my quest for musical organization. On July 212386-8260 13268 Itamarin addition to my teacher2021territorios para el arte 590908 2021 7 8182058 La Méthode como hermenéutica musical Homenaje a Edgar Morin por su 100º cumpleaños Iniesta Masmano [revista de investigación musical]:CIENCIAS DE LAS ARTES Y LAS LETRAS [UNESCO]revista de investigación musical: territorios para el arte 590908 2021 7 8182058 La Méthode como hermenéutica musical Homenaje a Edgar Morin por su 100º cumpleaños Iniesta Masmanothe schenkerian analysis. It is a review and extension of a few pages of my doctoral thesis [which emerged at the beginning of the 20th century]which emerged at the beginning of the 20th century: the schenkerian analysis. It is a review and extension of a few pages of my doctoral thesis
researchProduct

Substance use, medication adherence and outcome one year following a first episode of psychosis

2016

Both substance use and poor medication adherence are associated with poor outcome in psychosis. To clarify the contributions of substance use and poor medication adherence to poor outcome in the year following a first episode of psychosis, 205 patients were evaluated for use of tobacco, alcohol, cannabis and stimulants at their psychosis onset, and in a 1-year follow-up. Data on medication adherence and symptom remission were also collected. Patients had high rates of overall substance use before (37-65%) and after psychosis onset (45-66%). 44% showed poor medication adherence and 55% did not reach remission from psychosis. Nicotine dependence and cannabis use after psychosis onset signific…

Nicotine dependenceAdultMalePsychosismedicine.medical_specialtyFirst episode psychosisRemissionSubstance-Related DisordersMedication adherenceSubstance useCannabis useMedication AdherenceCannabis use; First episode psychosis; Medication adherence; Nicotine dependence; Remission; Substance use; Acute Disease03 medical and health sciencesYoung Adult0302 clinical medicineSettore M-PSI/08 - Psicologia ClinicamedicineHumansYoung adultCannabis use; First episode psychosis; Medication adherence; Nicotine dependence; Remission; Substance use; Acute Disease; Adult; Antipsychotic Agents; Female; Follow-Up Studies; Humans; Male; Medication Adherence; Middle Aged; Psychotic Disorders; Substance-Related Disorders; Treatment Outcome; Young AdultNicotine dependencePsychiatryMedication adherenceSettore MED/25 - PsichiatriaBiological PsychiatryFirst episodebiologyCannabis useMiddle Agedmedicine.diseasebiology.organism_classificationFirst episode psychosi030227 psychiatryTreatment OutcomePsychotic DisordersPsychiatry and Mental HealthAcute DiseaseFemaleCannabisSubstance usePsychology030217 neurology & neurosurgeryAntipsychotic AgentsFollow-Up Studies
researchProduct

The FIRST experiment at GSI

2012

The FIRST (Fragmentation of Ions Relevant for Space and Therapy) experiment at the SIS accelerator of GSI laboratory in Darmstadt has been designed for the measurement of ion fragmentation cross-sections at different angles and energies between 100 and 1000 MeV/nucleon. Nuclear fragmentation processes are relevant in several fields of basic research and applied physics and are of particular interest for tumor therapy and for space radiation protection applications. The start of the scientific program of the FIRST experiment was on summer 2011 and was focused on the measurement of 400 MeV/nucleon 12C beam fragmentation on thin (8 mm) graphite target. The detector is partly based on an alread…

Nuclear and High Energy PhysicsIon beamPhysics::Instrumentation and Detectorsmedicine.medical_treatmentNuclear physics[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]ScintillatorElementary-particleFIRST7. Clean energy01 natural sciencesParticle detectorWire chamberNuclear physicsDipole magnetFragmentationPARTICLE THERAPYhadrontherapy; fragmentation; nuclear physics; elementary-particle; instrumentation; experimental methodsHadrontherapy0103 physical sciencesmedicineNeutron detectionddc:530Gaseous detectorION-BEAM010306 general physicsNuclear ExperimentDETECTORInstrumentationGEANT4PARTICLE THERAPY; FLUKA CODE; ION-BEAM; FRAGMENTATION; BENCHMARKING; RADIOTHERAPY; TRANSPORT; DETECTOR; GEANT4; FIRSTPhysicsParticle therapyTime projection chamber010308 nuclear & particles physicsExperimental methodsDetectorScintillatorTRANSPORTSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)Hadrontherapy; Fragmentation; Nuclear physics; Elementary-particle; Experimental methods; InstrumentationFLUKA CODEBENCHMARKINGElementary-particle; Experimental methods; Fragmentation; Hadrontherapy; Instrumentation; Nuclear physics; Instrumentation; Nuclear and High Energy PhysicsRADIOTHERAPY
researchProduct

Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial

2014

BACKGROUND: In patients with relapsing-remitting MS (RRMS) fingolimod prevents disease relapses and delays disability progression. First dose administration of fingolimod is associated with a transient, dose-dependent decrease in heart rate (HR) in the 6 hours after drug intake.The aim of the study is to to assess safety and tolerability of the first dose of fingolimod in a cohort of Italian patients with RRMS without alternative therapeutic options. METHODS: Open-label, single arm, multicentre study. After the first dose of fingolimod, patients were observed for 6 hours and had their vital signs monitored hourly. Extended on-site monitoring was provided when required. RESULTS: Of the 906 p…

OncologyMaleNeurologyfingolimod multiple sclerosis treatment first dose safetyadministration /&/ dosage/adverse effects/analogs /&/ derivatives/therapeutic useImmunosuppressive AgentSphingosineMultiple SclerosiAtrioventricular Blockadministration /&/ dosage/adverse effects/therapeutic useGeneral MedicineMiddle AgedTolerabilityPropylene GlycolFingolimoddrug therapyTolerabilityAnesthesiaCohortAdolescent Adult Atrioventricular Block; chemically induced/epidemiology Drug Therapy; Combination Female Humans Immunosuppressive Agents; administration /&/ dosage/adverse effects/therapeutic use Male Middle Aged Multiple Sclerosis; drug therapy Propylene Glycols; administration /&/ dosage/adverse effects/therapeutic use Sphingosine; administration /&/ dosage/adverse effects/analogs /&/ derivatives/therapeutic use Young AdultCombinationDrug Therapy CombinationSettore MED/26 - NeurologiaFemaleAtrioventricular block; Bradycardia; Fingolimod; Multiple sclerosis; Safety; Tolerability; Adolescent; Adult; Atrioventricular Block; Drug Therapy Combination; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis; Propylene Glycols; Sphingosine; Young Adult; Neurology (clinical)SafetyAtrioventricular block Bradicardia Multiple sclerosis Fingolimod Safety TolerabilityImmunosuppressive AgentsResearch ArticleHumanmedicine.drugAdultmedicine.medical_specialtyMultiple SclerosisAdolescentClinical NeurologyYoung AdultFingolimod HydrochlorideInternal medicineBradycardiamedicineHumansNeurochemistryFingolimod Hydrochloridebusiness.industryMultiple sclerosisFingolimodmedicine.diseaseClinical trialPropylene GlycolsAtrioventricular block Bradycardia Multiple sclerosis Fingolimod Safety Tolerabilitychemically induced/epidemiologyNeurology (clinical)business
researchProduct

Quality of Life Analysis of TORCH, a Randomized Trial Testing First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Chemotherapy in Adva…

2012

INTRODUCTION:: The TORCH (Tarceva or Chemotherapy) trial randomized patients with advanced non-small-cell lung cancer to first-line erlotinib followed by second-line cisplatin/gemcitabine versus. standard inverse sequence. The trial, designed to test noninferiority in overall survival, was stopped at interim analysis because of inferior survival in the experimental arm. Quality of life (QoL), a secondary outcome, is reported here. METHODS:: QoL was assessed at baseline and every 3 weeks during first-line, using European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 and QLQ-lung cancer specific module (LC13). Mean changes from baseline within arms …

OncologyMaleerlotinibLung NeoplasmsHealth-related quality of lifeNSCLCchemotherapyDeoxycytidinelaw.inventionRandomized controlled trialQuality of lifelawCarcinoma Non-Small-Cell LungSurveys and QuestionnairesAntineoplastic Combined Chemotherapy ProtocolsSurveys and QuestionnaireQuality of life analysis of TORCHErlotinib HydrochloridePrognosishumanitiesOncologyResearch DesignAdvanced non–small-cell lung cancerCarcinoma Squamous CellFemaleErlotinibRandomized trialmedicine.drugHumanPulmonary and Respiratory Medicinemedicine.medical_specialtyPrognosiEGFRFirst-line treatmentfirst-line erlotinibsecond-line cisplatin/gemcitabine chemotherapyAdenocarcinomaNOFollow-Up StudieErlotinib HydrochlorideInternal medicineadvanced non-small-cell lung cancermedicineHumansLung cancerAdvanced non-small-cell lung cancer; Chemotherapy; EGFR; Erlotinib; First-line treatment; Health-related quality of life; Randomized trialQuality of life analysis of TORCH first-line erlotinib second-line cisplatin/gemcitabine chemotherapy advanced non-small-cell lung cancer.AgedNeoplasm StagingSalvage TherapyAntineoplastic Combined Chemotherapy Protocolbusiness.industryQuestionnaireCancerQuinazolinemedicine.diseaseInterim analysisGemcitabineGemcitabineSurgeryLung Neoplasmquality of lifeQuinazolinesCarcinoma Large CellCisplatinNeoplasm Recurrence LocalbusinessFollow-Up Studies
researchProduct

Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patient…

2020

<b><i>Background:</i></b> Different studies suggest that fulvestrant 500 mg every 28 days (HD-FUL) could be an active treatment in HR+ advanced breast cancer (ABC) patients even treated with aromatase inhibitors in the adjuvant setting. The aim of this analysis is to describe the outcome of ABC patients treated with HD-FUL as first-line treatment in terms of median duration of treatment and the overall response rate in a real-world setting. <b><i>Methods:</i></b> For the purpose of the present analysis, we considered two data sets of HR+ ABC patients collected in Italy between 2012 and 2015 (EVA and GIM-13 AMBRA studies). <b><i>Res…

Oncologymedicine.medical_specialtymedicine.drug_classPopulationAnastrozoleNOInternal medicineFulvestrant · First-line setting · Hormone receptor positive Advanced breast cancermedicineAdjuvant therapyProgression-free survivaleducationFulvestrantFirst-Line settingeducation.field_of_studyHormone receptor positiveAromatase inhibitorFulvestrantEVAbusiness.industrytrialsCancerEndocrine TherapyGIM-13medicine.diseaseEndocrine Therapy HR+/HER2– Advanced Breast Cancer High-Dose Fulvestrant First-Line setting EVA GIM-13 AMBRA trialsAdvanced breast cancer; First-line setting; Fulvestrant; Hormone receptor positiveOncologyHR+/HER2–Advanced Breast CancerSurgeryAMBRAbusinessHigh-DoseTamoxifenResearch Articlemedicine.drug
researchProduct

Seniority rules, worker mobility and wages : evidence from multi-country linked employer-employee data

2018

We construct multi-country employer-employee data to examine the consequences of last-in, first-out rules. We identify the effects by comparing worker exit rates between different units of the same firms operating in Sweden and Finland, two countries that have different seniority rules. We observe a relatively lower exit rate for more senior workers in Sweden in the shrinking firms and among the low-wage workers. These empirical patterns are consistent with last-in, first-out rules in Sweden providing protection from dismissals for the more senior workers among the worker groups to whom the rules are most relevant. Similarly, we observe a steeper seniority-wage profile in Sweden, suggesting…

Organizational Behavior and Human Resource ManagementEconomics and EconometricsLabour economicslast-in first-out rulesEmployment protection legislationseniority-wage profilehenkilöstöpolitiikkaeducationmulti-country linked employer-employee dataSeniority (financial)0502 economics and businesstyöntekijätEconomicsResizing050207 economics050205 econometrics irtisanomissuojaseniority rulesta51105 social sciencestyönantajatBargaining powerMultinational corporationmonikansalliset yrityksetemployment protection legislationConstruct (philosophy)ikäMulti countryLabour Economics
researchProduct